Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 142.531 |
|
|||||
| News | (2) |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Silexion Therapeutics Corporation | SLXNW | NASDAQ | Equity Warrant |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,0124 | 34,83% | 0,048 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,044 | 0,036 | 0,055 | 0,0478 | 0,0356 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen |
|---|---|---|---|---|
| 73 | 142.531 | 0,0528686 | 7.535 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:33:23 | formt | 110 | 0,048 | USD |
Finanzwerte SLXNW
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 76,95k | - | - | - | 0,29 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Silexion Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 17.1.2025 | 12:56 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.1.2025 | 12:44 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 16.1.2025 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 15.1.2025 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.1.2025 | 12:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.1.2025 | 23:02 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 14.1.2025 | 12:19 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 14.1.2025 | 12:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18.12.2024 | 12:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 17.12.2024 | 13:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10.12.2024 | 15:42 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 10.12.2024 | 15:41 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
Forum Silexion Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
SLXNW Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:SLXNW -
What is the current Silexion Therapeutics Corporation share price?
The current share price of Silexion Therapeutics Corporation is US$ 0,048
What is the 1 year trading range for Silexion Therapeutics Corporation share price?
Silexion Therapeutics Corporation has traded in the range of US$ 0,00 to US$ 0,00 during the past year
